Article

David W. Parke II, MD, named president of American Academy of Ophthalmology

San Francisco-As of Jan. 1, David W. Parke II, MD, assumed the role of president of the American Academy of Ophthalmology (AAO).

San Francisco-As of Jan. 1, David W. Parke II, MD, assumed the role of president of the American Academy of Ophthalmology (AAO), taking over from the departing president C.P. Wilkinson, MD. Dr. Parke's other leadership roles include the Edward L. Gaylord professor, chairman of the Department of Ophthalmology at the University of Oklahoma, and chief executive officer of the Dean A. McGee Eye Institute, Oklahoma City, OK.

"There has never been a more exciting time for ophthalmology as medical advances give ophthalmologists breakthrough treatment options to save vision," said Dr. Parke. "Ophthalmology is also faced with challenges ranging from Medicare reimbursement to scope of practice. I look forward to serving the academy and its members in the year ahead."

Dr. Parke has held several positions with the AAO. He has served on the academy's board of trustees since 2000, as trustee-at-large from 2000 to 2001, and as senior secretary for ophthalmic practice from 2002 to 2006. Academy committees he has served on include the instruction advisory committee, nominating committee, awards committee, and bylaws and rules committee.

"Few leaders come to this presidency post with this much experience and dedication to the Academy and the profession," said H. Dunbar Hoskins Jr., MD, executive vice president of the academy. "We are thrilled to have Dr. Parke lead us through this year."

Dr. Parke achieved his medical degree at Baylor College of Medicine in Houston and completed his residency at the Cullen Eye Institute, followed by a fellowship in medical retina and a subsequent fellowship in surgical retina.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.